MFPHMI Part I study materials
MFPHMI Part I study resources

MFPHMI Part I flashcards

MFPHMI Part I · Build recall with a focused review session.

32 cards. Read the term and the definition here. The deck at the top of this page is optional.

Incidence rate
Number of new cases of a disease occurring in a population at risk during a specified period, divided by the person-time at risk.
Prevalence
Proportion of a population with a disease at a given point (point prevalence) or during a period (period prevalence); depends on incidence and duration.
Relative risk
Ratio of disease incidence in exposed to incidence in unexposed; used in cohort studies and randomised trials to express strength of association.
Odds ratio
Ratio of odds of exposure in cases to odds in controls; approximates relative risk when the disease is rare; used in case-control studies.
Sensitivity
Proportion of people with the disease who correctly test positive; TP/(TP+FN); a highly sensitive test is useful for ruling out disease.
Specificity
Proportion of people without the disease who correctly test negative; TN/(TN+FP); a highly specific test is useful for confirming disease.
Positive predictive value
Proportion of people with a positive test who actually have the disease; rises with prevalence and with specificity of the test.
Herd immunity threshold
Proportion of a population that must be immune to interrupt transmission; calculated as 1 − 1/R0 for a homogeneously mixing population.
Standard error of mean
Standard deviation of the sampling distribution of the mean, equal to s/√n; decreases as sample size increases.
Type I error
Rejecting a true null hypothesis (false positive); its probability is denoted alpha, conventionally set at 0.05.
Statistical power
Probability of correctly rejecting a false null hypothesis (1 − beta); increases with larger sample size, larger effect size and lower variance.
Number needed to treat
Number of patients who must be treated to prevent one additional adverse outcome; reciprocal of the absolute risk reduction.
Absolute risk reduction
Difference in event rates between control and treatment groups; unlike relative risk reduction, it reflects baseline risk and clinical impact.
Confidence interval
Range of values within which the true population parameter is expected to lie with a stated probability, commonly 95%.
ANOVA
Parametric test comparing means across three or more independent groups by partitioning total variance into between-group and within-group components.
Basic reproduction number
Average number of secondary cases generated by one infectious case in a fully susceptible population; determines epidemic potential.
Case definition
Standard set of clinical, epidemiological and laboratory criteria used to classify individuals as suspected, probable or confirmed cases in an outbreak.
Notifiable disease
Disease that registered medical practitioners have a statutory duty to report to the proper officer of the local authority or UKHSA.
Contact tracing
Identifying and following up people who may have been exposed to an infectious case, to enable early diagnosis, treatment or isolation.
Vaccine efficacy
Percentage reduction in disease attack rate among vaccinated compared with unvaccinated individuals, calculated as (ARU − ARV)/ARU × 100.
Post-exposure prophylaxis
Intervention such as immunoglobulin, vaccine or antibiotics given after exposure to a pathogen to prevent or attenuate disease.
Droplet precautions
Infection control measures for pathogens spread by large respiratory droplets, including surgical masks for staff and spatial separation of patients.
Ottawa Charter
1986 WHO charter identifying five health promotion action areas: healthy public policy, supportive environments, community action, personal skills and reoriented services.
Stages of change model
Prochaska and DiClemente's cycle of pre-contemplation, contemplation, preparation, action, maintenance and relapse used to tailor behaviour change support.
Health Belief Model
Behaviour change model proposing that action depends on perceived susceptibility, severity, benefits, barriers, cues to action and self-efficacy.
Upstream intervention
Action targeting social, economic or environmental determinants of health, such as taxation or housing policy, rather than individual behaviour.
Health literacy
Capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions.
Social marketing
Application of commercial marketing principles, including product, price, place and promotion, to design programmes that promote health behaviour change.
Primordial prevention
Action to prevent the emergence of risk factors in a population, such as policies discouraging smoking uptake, before exposure occurs.
Secondary prevention
Early detection and treatment of established disease, for example through screening programmes, to improve prognosis and reduce complications.
Donabedian model
Framework for assessing healthcare quality through three dimensions: structure (resources), process (activities) and outcome (results).
Health needs assessment
Systematic method of identifying health needs of a population using epidemiological, comparative and corporate approaches to inform commissioning.